AGP Executive Report
Last update: 6 hours agoCancer Care & Research: UCLA Health hired nuclear medicine physician-scientist Dr. Amir Iravani to lead its Theranostics Program, aiming to expand targeted radiopharmaceutical trials and precision imaging. Microbes & Hormones: A new study reports a urinary-tract bacterium can convert DHEA into testosterone in lab conditions, pointing to a previously unknown microbial route tied to androgen biology. Public Health: New Zealand surveillance shows STI rates fell in 2025, but antimicrobial resistance remains a concern after an extensively drug-resistant gonorrhea isolate was detected. Volcano Forecasting: Kīlauea’s summit eruption is paused, with USGS projecting the next lava-fountaining episode could fall in Sept. 7–13. Climate & Water: Researchers warn that cold-water management is crucial for California salmon survival as heat strains river conditions. Energy Materials: UW-Madison researchers report a lead-free tin perovskite solar-cell material that resists air and moisture degradation, using a “raincoat” style protective approach. Biotech & Business: Pfizer’s CFO stepped down, while Argenx’s new CEO outlined growth plans after strong Vyvgart sales and a major acquisition.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
